Driven by the growing demand of the Chinese health care market, there are many opportunities in this sectors. Clients and investors benefit from the support of on-the-ground advice and a nuanced cultural understanding. J Rich Capital works closely with pharmaceutical companies, regulators, and financial institutions to develop a comprehensive understanding of the markets in China, USA and Europe. By utilizing our extended network, we can bring together companies and investors to carry out license trading, distribution rights buyouts, as well as mergers and acquisitions. Our expertise in this growing industry helps our clients achieve superior results.